Sheba Medical Center, ARC & Mana.bio Announce Partnership to Revolutionize RNA Delivery for Cancer & Autoimmune Diseases

We are thrilled to announce that Mana.bio has partnered with Sheba Medical Center ARC to drive advancements in RNA-based therapies for cancer and autoimmune diseases. This collaboration will combine Mana.bio's cutting-edge AI-powered lipid nanoparticle (LNP) platform with Sheba ARC’s world-renowned clinical expertise.

By working together, we aim to revolutionize RNA delivery, making treatments more precise, potent, and safer for patients facing complex diseases. Mana.bio’s machine learning-driven approach to LNP design has the potential to optimize therapeutic outcomes, transforming the future of medicine.

This partnership reflects our shared vision of innovation and commitment to addressing significant unmet medical needs. We are excited about the possibilities this collaboration will unlock for developing breakthrough RNA therapies.

Read the full article here.